Tyra Biosciences Inc. Rings the Closing Bell in Celebration of its IPO

ABOUT THIS EVENT

Tyra Biosciences (Nasdaq: TYRA), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer, visits the Nasdaq MarketSite in Times Square to ring the Closing Bell.

Nasdaq Originals Exclusive insights on the forces shaping the convergence of technology, business and sports. Explore